MYCCMYCN

Alexander Chernov1,2, Ekaterina Batotsyrenova1, Sergey Zheregelya1

  • 1Federal State Budgetary Educational Institution of Higher Education, "Saint Petersburg State Pediatric Medical University of the Ministry of Health of Russia",194100 Saint Petersburg, Russia.

PubMed
概括

俄罗斯脑髓母细胞瘤患者的MYC基因放大预示着生存率较低和复发风险较高. 这一发现有助于更好地分层患者的风险,以量身定制治疗强度和持续时间.